# Inclisiran Sodium S.C. Injection 300mg Syringe (レクビオ皮下注３００ｍｇシリンジ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2189403G1029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2189403G1029
- **Product name (Japanese):** レクビオ皮下注３００ｍｇシリンジ
- **English title:** Inclisiran Sodium S.C. Injection 300mg Syringe
- **Active ingredient:** インクリシランナトリウム
- **Active ingredient (INN):** Inclisiran Sodium
- **Strength / unit:** ３００ｍｇ１．５ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 21 Cardiovascular agents (循環器官用薬) › 218 Antihyperlipidemics (高脂血症用剤)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 394758 per ３００ｍｇ１．５ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2189403G1029
- **JSON:** https://www.nifujipharma.com/api/drugs/2189403G1029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Inclisiran%20Sodium%20S.C.%20Injection%20300mg%20Syringe%20(%E3%83%AC%E3%82%AF%E3%83%93%E3%82%AA%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%93%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8)%20%2F%20YJ%202189403G1029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.